Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Obstet Gynecol. 2017 Mar;129(3):439–447. doi: 10.1097/AOG.0000000000001867

Table 5.

Demographic and clinical characteristics of women with LGCS after propensity score matching for utilization of lymph node dissection.

Lymph Node Dissection No Lymph Node
Dissection
P
N 202 202
Mean Age (Years, SD) 54.08 (15.14) 55.54 (14.83) 0.3
Race [N (%)] 0.6
White 185 (91.6) 187 (92.6)
African-America 10 (5.0) 11 (5.4)
Other 7 (3.5) 4 (2.0)
Period of Diagnosis [N (%)] 0.3
2003–2005 87 (43.1) 81 (40.1)
2006–2008 54 (26.7) 68 (33.7)
2009–2011 61 (30.2) 53 (26.2)
Facility Type [N (%)] 0.8
Academic 91 (45.0) 96 (47.5)
Community 10 (5.0) 9 (4.5)
Comprehensive 101 (50.0) 97 (48.0)
Urban vs. Rural [N (%)] 0.8
Urban 188 (93.1) 188 (93.1)
Rural 2 (1.0) 3 (1.5)
Unknown 12 (5.9) 11 (5.4)
Registry Location [N (%)] 0.9
Northeast 40 (19.8) 37 (18.3)
Midwest 46 (22.8) 50 (24.8)
South 93 (46.0) 89 (44.1)
West 23 (11.4) 26 (12.9)
Income [N (%)] 0.9
1st Quartile 26 (12.9) 25 (12.4)
2nd Quartile 53 (26.2) 56 (27.7)
3rd Quartile 58 (28.7) 59 (29.2)
4th Quartile 59 (29.2) 55 (27.2)
Unknown 6 (3.0) 7 (3.5)
Insurance [N (%)] 0.9
None 17 (8.4) 15 (7.4%)
Private 111 (55.0) 111 (55.0%)
Medicare 50 (24.8) 54 (26.7%)
Other Government 16 (7.9) 17 (8.4%)
Unknown 8 (4.0) 5 (2.5%)
Charlson/Deyo Score [N
(%)]
0.7
0 167 (82.7) 168 (83.2)
1 31 (15.3) 28 (13.9)
2 4 (2.0) 6 (3.0)
Education Level [N (%)] 0.7
<7% 48 (23.8) 46 (22.8)
7–13% 75 (37.1) 65 (32.2)
13–21% 48 (23.8) 53 (26.2)
>21% 25 (12.4) 31 (15.3)
Unknown 6 (3.0) 7 (3.5)
Stage [N (%)] 171 (84.7) 165 (81.7)
IIIC 31 (15.3) 37 (18.3)
IV
Tumor size [N (%)] 0.7
<1cm 4 (2.0) 2 (1.0)
<2cm 9 (4.5) 9 (4.5)
<3cm 10 (5.0) 6 (3.0)
<4cm 5 (2.5) 4 (2.0)
<5cm 12 (5.9) 8 (4.0)
> 5cm 95 (47.0) 98 (48.5)
*

SD: Standard Deviation.